Narcolepsy patients' blood-based miRNA expression profiling: miRNA expression differences with Pandemrix vaccination

Area of Science:

• Neuroscience
• Genetics
• Immunology

Background:

• Narcolepsy is a neurological sleep disorder with excessive daytime sleepiness.
• An increase in narcolepsy cases was observed in children and adolescents vaccinated with the Pandemrix vaccine in Finland and Sweden.
• MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and are implicated in various biological processes and diseases.

Purpose of the Study:

• To identify specific miRNAs involved in narcolepsy.
• To investigate the association between miRNA expression and Pandemrix vaccination in narcolepsy patients.
• To explore potential mechanisms underlying narcolepsy pathogenesis related to miRNA dysregulation.

Main Methods:

• Global miRNA profiling using miRNA microarrays.
• Quantitative real-time PCR (RT-PCR) for verification of miRNA expression.
• Analysis of miRNA expression in 20 narcolepsy patients (Pandemrix-associated and non-associated) and 17 controls (vaccinated and non-vaccinated).

Main Results:

• Eleven miRNAs were differentially expressed between all narcolepsy patients and controls.
• Seventeen miRNAs showed significant differential expression between Pandemrix-non-associated narcolepsy patients and non-vaccinated healthy controls.
• MiR-188-5p and miR-4499 were over-expressed in narcolepsy patients, while miR-1470 and miR-4455 were under-expressed in Pandemrix-associated narcolepsy patients compared to Pandemrix-non-associated patients.

Conclusions:

• Distinct miRNA expression patterns were identified in narcolepsy patients.
• These miRNA alterations are potentially linked to mRNA targets involved in brain-related pathways and neurological disorders.
• The findings suggest a role for specific miRNAs in the pathogenesis of narcolepsy, possibly influenced by Pandemrix vaccination.